{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:49:49Z","timestamp":1785581389706,"version":"3.56.0"},"reference-count":46,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2019,11,13]]},"DOI":"10.3233\/ch-199226","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T14:02:21Z","timestamp":1568988141000},"page":"249-260","source":"Crossref","is-referenced-by-count":15,"title":["NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies"],"prefix":"10.1177","volume":"73","author":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[{"name":"Fraunhofer Project Group PZ-Syn of the Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam, Germany, located at the Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kammerer","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Heiner","family":"K\u00fcpper","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CH-199226_ref1","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Scientific Reports"},{"issue":"1","key":"10.3233\/CH-199226_ref2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.3233\/CH-199226_ref3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/me.2010-0236","article-title":"Transcriptional regulation of the human P450 oxidoreductase gene: Hormonal regulation and influence of promoter polymorphisms","volume":"25","author":"Tee","year":"2011","journal-title":"Molecular Endocrinology"},{"issue":"1-2","key":"10.3233\/CH-199226_ref4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","article-title":"Consequences of POR mutations and polymorphisms","volume":"336","author":"Miller","year":"2011","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"10.3233\/CH-199226_ref5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2007","journal-title":"Chemical Research in Toxicology"},{"issue":"6","key":"10.3233\/CH-199226_ref6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","article-title":"Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation","volume":"392","author":"Zanger","year":"2008","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"3","key":"10.3233\/CH-199226_ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40291-013-0028-5","article-title":"Applications of CYP450 testing in the clinical setting","volume":"17","author":"Samer","year":"2013","journal-title":"Molecular Diagnosis & Therapy"},{"key":"10.3233\/CH-199226_ref8","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.3233\/CH-199226_ref9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metabolism Reviews"},{"issue":"5","key":"10.3233\/CH-199226_ref10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200043335414","article-title":"Human hepatocytes in primary culture: The choice to investigate drug metabolism in man","volume":"5","author":"Gomez-Lechon","year":"2004","journal-title":"Current Drug Metabolism"},{"issue":"1","key":"10.3233\/CH-199226_ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-8278(86)80140-4","article-title":"Cryopreservation of adult human hepatocytes: The influence of deep freezing storage on the viability, cell seeding, survival, fine structures and albumin synthesis in primary cultures","volume":"3","author":"Rijntjes","year":"1986","journal-title":"Journal of Hepatology"},{"issue":"245","key":"10.3233\/CH-199226_ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/scitranslmed.3005975","article-title":"Cell and tissue engineering for liver disease","volume":"6","author":"Bhatia","year":"2014","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10.3233\/CH-199226_ref13","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1159\/000490934","article-title":"Effect of P450 oxidoreductase polymorphisms on the metabolic activities of ten cytochrome P450s varied by polymorphic CYP genotypes in human liver microsomes","volume":"47","author":"Fang","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"4","key":"10.3233\/CH-199226_ref14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/1389200219666180108160046","article-title":"Inter-individual variability in activity of the major drug metabolizing enzymes in liver homogenates of 20 individuals","volume":"19","author":"den Braver-Sewradj","year":"2018","journal-title":"Current Drug Metabolism"},{"issue":"2","key":"10.3233\/CH-199226_ref15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/CH-189409","article-title":"Effect of lipopolysaccharide on the adherence of human umbilical vein endothelial cells (HUVEC) on a natural substrate","volume":"71","author":"Kr\u00fcger-Genge","year":"2019","journal-title":"Clin Hemorheol Microcirc"},{"issue":"4","key":"10.3233\/CH-199226_ref16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/CH-189320","article-title":"Inhibition of GPR 55 improves dysregulated immune response in experimental sepsis","volume":"70","author":"Zhou","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"10.3233\/CH-199226_ref17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0887-2333(03)00146-2","article-title":"Activation of signalling pathways during hepatocyte isolation: Relevance to toxicology in vitro","volume":"18","author":"Paine","year":"2004","journal-title":"Toxicology in Vitro"},{"issue":"6","key":"10.3233\/CH-199226_ref18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/138920006778017759","article-title":"Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures","volume":"7","author":"Elaut","year":"2006","journal-title":"Current Drug Metabolism"},{"issue":"4","key":"10.3233\/CH-199226_ref19","doi-asserted-by":"crossref","first-page":"e0124867","DOI":"10.1371\/journal.pone.0124867","article-title":"Regulation of liver enriched transcription factors in rat hepatocytes cultures on collagen and EHS sarcoma matrices","volume":"10","author":"Borlak","year":"2015","journal-title":"PloS One"},{"issue":"10-11","key":"10.3233\/CH-199226_ref20","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/00498250701534893","article-title":"Induction of hepatic cytochrome P450 enzymes: Methods, mechanisms, recommendations, and in vitro\u2013in vivo correlations","volume":"37","author":"Hewitt","year":"2007","journal-title":"Xenobiotica"},{"key":"10.3233\/CH-199226_ref21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2015.10.009","article-title":"Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity","volume":"255","author":"Xuan","year":"2016","journal-title":"Chemico-Biological Interactions"},{"issue":"1","key":"10.3233\/CH-199226_ref22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"issue":"2","key":"10.3233\/CH-199226_ref23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/cells8020192","article-title":"In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes","volume":"8","author":"Tascher","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.3233\/CH-199226_ref24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.3233\/CH-199226_ref25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/JCB-189013","article-title":"HepG2 cells with recombinant cytochrome P450 enzyme overexpression: Their use and limitation as in vitro liver model","volume":"5","author":"Steinbrecht","year":"2019","journal-title":"Journal of Cellular Biotechnology"},{"issue":"2","key":"10.3233\/CH-199226_ref26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JCB-179012","article-title":"Human hepatocyte systems for in vitro toxicology analysis","volume":"3","author":"Kammerer","year":"2018","journal-title":"Journal of Cellular Biotechnology"},{"issue":"1","key":"10.3233\/CH-199226_ref27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JCB-15002","article-title":"Generation of cytochrome P450 3A4-overexpressing HepG2 cell clones for standardization of hepatocellular testosterone 6\u03b2-hydroxylation activity","volume":"1","author":"Herzog","year":"2015","journal-title":"Journal of Cellular Biotechnology"},{"issue":"10","key":"10.3233\/CH-199226_ref28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/00498254.2012.675093","article-title":"Generation of proliferating human hepatocytes using upcyte\u00ae technology: Characterisation and applications in induction and cytotoxicity assays","volume":"42","author":"Burkard","year":"2012","journal-title":"Xenobiotica"},{"issue":"3","key":"10.3233\/CH-199226_ref29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cbin.10574","article-title":"Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures","volume":"40","author":"Herzog","year":"2016","journal-title":"Cell Biology International"},{"issue":"1-2","key":"10.3233\/CH-199226_ref30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mrgentox.2013.09.008","article-title":"Optimization of upcyte\u00ae human hepatocytes for the in vitro micronucleus assay","volume":"758","author":"N\u00f6renberg","year":"2013","journal-title":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"},{"issue":"3","key":"10.3233\/CH-199226_ref31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/dmd.115.067348","article-title":"Upcyte human hepatocytes: A potent in vitro tool for the prediction of hepatic clearance of metabolically stable compounds","volume":"44","author":"Schaefer","year":"2016","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.3233\/CH-199226_ref32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","article-title":"Human upcyte hepatocytes: Characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing","volume":"152","author":"Tolosa","year":"2016","journal-title":"Toxicological Sciences"},{"issue":"5","key":"10.3233\/CH-199226_ref33","doi-asserted-by":"crossref","first-page":"e00161","DOI":"10.1002\/prp2.161","article-title":"Applicability of second-generation upcyte\u00ae human hepatocytes for use in CYP inhibition and induction studies","volume":"3","author":"Ramachandran","year":"2015","journal-title":"Pharmacology Research & Perspectives"},{"issue":"1","key":"10.3233\/CH-199226_ref34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.112.048991","article-title":"NADPH\u2013cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology","volume":"41","author":"Riddick","year":"2013","journal-title":"Drug Metabolism and Disposition"},{"issue":"4","key":"10.3233\/CH-199226_ref35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/17425255.4.4.439","article-title":"P450 oxidoreductase: Genetic polymorphisms and implications for drug metabolism and toxicity","volume":"4","author":"Hart","year":"2008","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.3233\/CH-199226_ref36","doi-asserted-by":"crossref","unstructured":"Gomes AM , Winter S , Klein K , Turpeinen M , Schaeffeler E , Schwab M , et al. Pharmacogenomics of human liver cytochrome P450 oxidoreductase: Multifactorial analysis and impact on microsomal drug oxidation. 2009.","DOI":"10.2217\/pgs.09.7"},{"issue":"1","key":"10.3233\/CH-199226_ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2010.09.035","article-title":"Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism","volume":"401","author":"Fl\u00fcck","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"10.3233\/CH-199226_ref38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/dmd.116.069849","article-title":"Correlation of cytochrome P450 oxidoreductase expression with the expression of 10 isoforms of cytochrome P450 in human liver","volume":"44","author":"Zhang","year":"2016","journal-title":"Drug Metabolism and Disposition"},{"issue":"3","key":"10.3233\/CH-199226_ref39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.3233\/CH-199226_ref40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nature Genetics"},{"issue":"39","key":"10.3233\/CH-199226_ref41","doi-asserted-by":"crossref","first-page":"20487","DOI":"10.1074\/jbc.M116.716019","article-title":"Instability of the human cytochrome P450 reductase A287P variant is the major contributor to its Antley-Bixler syndrome-like phenotype","volume":"291","author":"McCammon","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.3233\/CH-199226_ref42","doi-asserted-by":"crossref","first-page":"e38495","DOI":"10.1371\/journal.pone.0038495","article-title":"Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6","volume":"7","author":"Chen","year":"2012","journal-title":"PloS One"},{"key":"10.3233\/CH-199226_ref43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fphar.2017.00580","article-title":"Altered CYP19A1 and CYP3A4 activities due to mutations A115V, T142A, Q153R and P284L in the human P450 oxidoreductase","volume":"8","author":"Udhane","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"5259","key":"10.3233\/CH-199226_ref44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"5","key":"10.3233\/CH-199226_ref45","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","article-title":"Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations","volume":"105","author":"Huang","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.3233\/CH-199226_ref46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(03)00031-7","article-title":"Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes","volume":"98","author":"Backes","year":"2003","journal-title":"Pharmacology & Therapeutics"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-199226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:07:45Z","timestamp":1777388865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-199226"}},"subtitle":[],"editor":[{"given":"P.","family":"Wiggermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"A.","family":"Kr\u00fcger-Genge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"F.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":46,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/ch-199226","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]}}}